Therefore, SGLT2i also exists for pancreatic cancer similar to breast cancer, inhibiting tumor growth not through SGLT2 but through other pathways, but larger clinical studies are needed. The gene discussed is SLC5A2; the disease is familial pancreatic carcinoma.